Poland – Pharmaceutical products – Successful delivery of medicinal products
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
1. The subject of the order is the successive delivery of medicinal products. 2. The subject of the order includes 2 (two) parts (packages). 3. Lot no. 1/package no. 1. 3.1. The subject of the order is the successive delivery of medicinal products containing the active substance dupilumab (Dupixent 300 mg solution for injection in a pre-filled syringe) for the purposes of implementing a non-commercial clinical trial: "Use of dupilumab in treatment of slow systemic mastocytosis with skin involvement - MAnaskin” as part of the competition for head-to-head research in the field of